Reviva Pharmaceuticals
RVPH
RVPH
33 hedge funds and large institutions have $14.9M invested in Reviva Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7.09% more ownership
Funds ownership: 22.97% → 30.06% (+7.1%)
6% more funds holding
Funds holding: 31 → 33 (+2)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
33
Holding in Top 10
–
Calls
$422K
Puts
$132K
Top Buyers
| 1 | +$4.59M | |
| 2 | +$852K | |
| 3 | +$723K | |
| 4 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
+$86.4K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$66.5K |
Top Sellers
| 1 | -$3.66M | |
| 2 | -$1.31M | |
| 3 | -$303K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$187K |
| 5 |
Morgan Stanley
New York
|
-$17K |